Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹604 Cr
Revenue (TTM)
₹120 Cr
Net Profit (TTM)
₹21 Cr
ROE
40.4 %
ROCE
24.8 %
P/E Ratio
29.4
P/B Ratio
2.8
Industry P/E
34.04
EV/EBITDA
19.5
Div. Yield
0 %
Debt to Equity
0.8
Book Value
₹20.2
EPS
₹5.1
Face value
10
Shares outstanding
53,151,500
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Anlon Healthcare
| -25.0 | 4.3 | -23.7 | -- | -- | -- | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Anlon Healthcare
|
113.2 | 604.1 | 120.3 | 20.5 | -- | 40.4 | 29.4 | 2.8 |
| 352.7 | 3,213.2 | 2,521.8 | 202.5 | 9.6 | 14.3 | 15.9 | 2.1 | |
| 989.6 | 12,119.0 | 2,512.3 | 543.7 | 28.3 | 19.3 | 22.3 | 3.8 | |
| 357.4 | 6,190.1 | 1,053.1 | 293.6 | 32.3 | 24.6 | 21.1 | 4.8 | |
| 1,025.1 | 10,733.1 | 1,158.7 | 309.6 | 31.9 | 17.3 | 34.3 | 5.7 | |
| 1,547.6 | 29,354.2 | 8,850.1 | 894.8 | 15.2 | 19.8 | 33.7 | 5.9 | |
| 12,433.0 | 15,953.0 | 1,575.1 | 179.1 | 14.9 | 11.4 | 89.1 | 9.6 | |
| 784.3 | 3,617.1 | 588.5 | 102.9 | 22.1 | 12.7 | 35.6 | 4.3 | |
| 615.1 | 6,946.9 | 502.0 | 138.7 | -- | 32.8 | 50.1 | 8.0 | |
| 158.0 | 4,151.0 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 6.2 |
No Review & Analysis are available.
--
Incorporated
2013
Chairman
Punitkumar R Rasadia
Managing Director
Punitkumar R Rasadia
Headquarters
Rajkot, Gujarat
Website
Looking for more details about Anlon Healthcare Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The share price of Anlon Healthcare Ltd is ₹113.15 (NSE) and ₹113.65 (BSE) as of 02-Apr-2026 IST. Anlon Healthcare Ltd has given a return of --% in the last 1 years.
The P/E ratio of Anlon Healthcare Ltd is 29.44 times as on 02-Apr-2026, a 14 discount to its peers’ median range of 34.04 times.
The P/B ratio of Anlon Healthcare Ltd is 2.75 times as on 02-Apr-2026, a 32 discount to its peers’ median range of 4.05 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
The 52-week high and low of Anlon Healthcare Ltd are Rs 172.75 and Rs 90.78 as of 05-Apr-2026.
Anlon Healthcare Ltd has a market capitalisation of ₹ 604 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Anlon Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹0.08
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.